EUROPEAN PATENT GRANTED TO QUEEN MARY UNIVERSITY LONDON FOR MEGAKARYOCYTE ANALYSIS TO ASSESS AGGRESSIVENESS OF PROSTATE CANCER ANGLE holds worldwide exclusive option over all megakaryocyte intellectual property Presence of megakaryocytes in prostate cancer linked...
British scientists said the technique, which picks up circulating cancer cells in a patient’s blood, could be available on the NHS in as little as three years. Prostate cancer is the most common cancer among British men, with 47,000 diagnoses a year. Currently, men...
For initial queries, please contact Lessia Djakowska, Office Manager or fill in the contact form
020 7882 5391